Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3238 USD | -2.47% | +28.24% | -84.73% |
28/03 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
28/03 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01/15/01 | |
Irina Pestrikova
DFI | Director of Finance/CFO | 38 | 18/21/18 |
Michael Thornton
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/07/01 |
Steve Freeman
HRO | Human Resources Officer | - | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 01/13/01 | |
Alexander Tokman
BRD | Director/Board Member | 62 | 01/08/01 |
Michael Harsh
BRD | Director/Board Member | 69 | 01/15/01 |
Louis Basenese
BRD | Director/Board Member | 46 | 09/20/09 |
Chief Executive Officer | 58 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,035,659 | 10,687,672 ( 96.85 %) | 0 | 96.85 % |
Stock B | 0 | 141,397 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.73% | 3.66M | |
+23.48% | 48.09B | |
+46.90% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+8.97% | 24.89B | |
-20.17% | 19.01B | |
+28.49% | 12.09B | |
+0.54% | 11.88B | |
-1.06% | 11.8B |
- Stock Market
- Equities
- NDRA Stock
- Company ENDRA Life Sciences Inc.